Trials / Withdrawn
WithdrawnNCT07071389
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Lo.Li.Pharma s.r.l · Industry
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
Prospective, controlled study. Administration of a specifically formulated supplement to women prescribed oral contraceptives. Evaluation of: a) reduction of adverse effects of the treatment; b) improvement of patients' quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Zyxelle | Patients in the study group receive Zyxelle dietary supplement along with the oral contraceptive |
| DRUG | Oral contraceptive | Patients in the study group receive daily dose of estroprogestinic oral contraceptive |
Timeline
- Start date
- 2018-01-08
- Primary completion
- 2018-12-21
- Completion
- 2018-12-21
- First posted
- 2025-07-17
- Last updated
- 2025-07-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07071389. Inclusion in this directory is not an endorsement.